De Novo Posttransplantation Nonlymphoproliferative Malignancies in Liver Transplant Recipients

Transplantation Proceedings

Volumn 39, Issue 10, 2007, Pages 3284-3286

  Boin, I ^a   Leonardi, M I ^a   Stucchi, R B ^a   Ataide, E C ^a   Almeida, J R ^a   Barros, R H ^a   Leonardi, L S ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; TACROLIMUS;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CLINICAL ARTICLE; DRUG DOSE REDUCTION; HEAD AND NECK CANCER; HERPES SIMPLEX VIRUS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTESTINE OBSTRUCTION; KAPOSI SARCOMA; LIVER TRANSPLANTATION; MALE; MALIGNANT NEOPLASTIC DISEASE; MORTALITY; ORTHOTOPIC TRANSPLANTATION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RECTUM CARCINOMA; RISK FACTOR; SKIN CANCER; SMOKING; SURVIVAL TIME;

FEMALE; HUMANS; INCIDENCE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; NEOPLASMS; POSTOPERATIVE COMPLICATIONS; PRECANCEROUS CONDITIONS; RETROSPECTIVE STUDIES;

EID: 37049036125     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2007.07.084     Document Type: Article

References (19)

1. Jain A., Nalesnik M., Reyes J., et al. Posttransplant lymphoproliferative disorders in liver transplantation: a 20-year experience. Ann Surg 236 (2002) 429
2. Xiol X., Guardiola J., Menendez S., et al. Risk factors for development of de novo neoplasia after liver transplantation. Liver Transplant 7 (2001) 971
3. Haagsma E.B., Hagens V.E., Schaapveld M., et al. Increased cancer risk after liver transplantation: a population-based study. J Hepatol 34 (2001) 84
4. Galve M.L., Cuervas-Mons V., Figueras J., et al. Incidence and outcome of de novo malignancies after liver transplantation. Transplant Proc 31 (1999) 1275
5. Fung J.J., Jain A., Kwak E.J., et al. De novo malignancies after liver transplantation: a major cause of late death. Liver Transpl 7 11 suppl 1 (2001) S109
6. Sheiner P.A., Magliocca J.F., Bodian C.A., et al. Long-term medical complications in patients surviving > or = 5 years after liver transplant. Transplantation 69 (2000) 781
7. de Kroon L., Drent G., van den Berg A.P., et al. Current health status of patients who have survived for more than 15 years after liver transplantation. Neth J Med 65 (2007) 252
8. Menachem Y., Safadi R., Ashur Y., et al. Premalignant conditions: risk factor for postliver transplantation malignancy. Transplant Proc 33 (2001) 2935
9. Duvoux C., Delacroix I., Richardet J.P., et al. Increased incidence of oropharyngeal squamous cell carcinomas after liver transplantation for alcoholic cirrhosis. Transplantation 67 (1999) 418
10. Jonas S., Rayes N., Neumann U., et al. De novo malignancies after liver transplantation using tacrolimus-based protocols or cyclosporine-based quadruple immunosuppression with an interleukin-2 receptor antibody or antithymocyte globulin. Cancer 80 (1997) 1141
11. Jonas S., Bechstein W.O., Rayes N., et al. Posttransplant malignancy and newer immunosuppressive protocols after liver transplantation. Transplant Proc 28 (1996) 3246
12. Mithoefer A.B., Supran S., Freeman R.B., et al. Risk factors associated with the development of skin cancer after liver transplantation. Liver Transpl 8 (2002) 939
13. Jain A.B., Yee L.D., Nalesnik M.A., et al. Comparative incidence of de novo nonlymphoid malignancies after liver transplantation under tacrolimus using surveillance epidemiologic end result data. Transplantation 66 (1998) 1193
14. Saigal S., Norris S., Muiesan P., et al. Evidence of differential risk for posttransplantation malignancy based on pretransplantation cause in patients undergoing liver transplantation. Liver Transpl 8 (2002) 482
15. Higashi H., Yanaga K., Marsh J.W., et al. Development of colon cancer after liver transplantation for primary sclerosing cholangitis associated with ulcerative colitis. Hepatology 11 (1990) 477
16. Atassi T., and Thuluvath P.J. Risk of colorectal adenoma in liver transplant recipients compared to immunocompetent control population undergoing routine screening colonoscopy. Clin Gastroenterol 37 (2003) 72
17. Romero-Vargas M.E., Flores-Cortes M., Valera Z., et al. Cancers of new appearance in liver transplant recipientsincidence and evolution. Transplant Proc 38 (2006) 2508
18. Euvrad S., and Kanitakis J. Skin cancers after liver transplantation: what to do?. J Hepatol 44 (2006) 27
19. Jain A., DiMartini A., Kashyap R., et al. Long-term follow-up after liver transplantation for alcoholic liver disease under tacrolimus. Transplantation 70 (2000) 1335